There have been multiple accounts created with the sole purpose of posting advertisement posts or replies containing unsolicited advertising.

Accounts which solely post advertisements, or persistently post them may be terminated.

rusticus , to news in A former US surgeon general says he went to the ER for dehydration and ended up with a $5,000 bill. He called the healthcare system 'broken.'

Fuck this joker. He’s the IDIOT that said, as the SURGEON GENERAL, “Seriously people - STOP BUYING MASKS! They are NOT effective in preventing general public from catching , but if healthcare providers can’t get them to care for sick patients, it puts them and our communities at risk!” (Tweet was then deleted). He should lose his medical license and be imprisoned for the excessive number of deaths his lies caused.

tomkindlon , to disability
@tomkindlon@disabled.social avatar
tomkindlon OP ,
@tomkindlon@disabled.social avatar

2/

"In the early days of the pandemic we were known as the clinically vulnerable: now we are rarely spoken about at all. I cannot remember the last time I saw the mainstream media address our existence – it is as though we disappeared in 2022 when the final restrictions were lifted and society returned to normal. In reality, we are still here."

@longcovid @covid19 @novid @mecfs @chronicillness @spoonies @disability

Email2TootBot , to psychology
@Email2TootBot@mastodon.clinicians-exchange.org avatar

Email2Toot Robot. Please see entry below for author.
.
TITLE: COVID news

Thanks Dr. Lepkowsky

-------- Forwarded Message -------

Disclaimer: The data in this column come from either mainstream news
media sources or scientific research published in peer-reviewed
journals (each category can be determined by following the links in
the reference section). This column's author acknowledges the cultural
bias of the world scientific community in its belief that the
scientific method is the most viable available alternative for
assessing COVID-19 and its effects in an objective manner through a
structured process of observable and repeatable hypothesis testing.

Summary: No one planning holiday gatherings or travel wants to hear
this, but the rise of a new COVID-19 variant, JN.1, is concerning
experts (see "New COVID Variant JN.1 Could Disrupt Holiday Plans,"
"New SARS-CoV-2 variant JN.1 shows increased transmissibility and
immune resistance" and "Update on SARS-CoV-2 Variant JN.1 Being
Tracked by CDC" under Virology & Epidemiology).

In addition, an emerging variant of COVID-19 called BA.2.86 that
caused alarm earlier this summer has landed on the CDC's radar again
(see "New CDC Advisory Once Again Flags BA.2.86 COVID Variant" under
Virology & Epidemiology).

The U.S. government has expanded a program offering free COVID-19 and
flu tests and treatment (see "Federal Program Offers Free COVID, Flu
At-Home Tests, Treatments" under Policy).

Regional estimates of long COVID vary from less than 4% to more than
24% (see "Wide Regional Variation in Diagnosis of Long COVID" under
COVID Complications).

The loss of smell and taste associated with COVDI-19 infection usually
resolves, but can take up to three years to do so (see "Sensory
Comeback: New Findings Show the Path to Smell and Taste Recovery After
COVID" under COVID Complications).

COVID-19 combined with RSV and the flu to form a "Tripledemic" (see
"'Tripledemic': Your Questions Answered" under Media News).

COVID vaccination demonstrably reduces emergency department visits for
children with COVID-19 (see "Effectiveness of Monovalent and Bivalent
mRNA Vaccines in Preventing COVID-19–Associated Emergency Department
and Urgent Care Encounters Among Children Aged 6 Months–5 Years" under
Vaccines, Treatment & Testing).

Long COVID cases now account for 6% of all workers' compensation
claims, but few are recognized (see "6% of Workers' Comp Cases Are for
Long COVID, But Many Can't Collect" under Policy).

New evidence shows for the first time that the virus that causes COVID
directly infects atherosclerotic plaques in the coronary arteries,
producing a persistent inflammatory response (see "COVID Coronary
Plaque Infection Confirms CV Risk" under COVID Complications).

Paxlovid (Nirmatrelvir-ritonavir) doesn't reduce the incidence of most
post-COVID conditions (see "Nirmatrelvir-Ritonavir Ineffective at
Reducing Most Post-COVID Conditions" under Vaccines, Treatment &
Testing).

The risk for Guillain-Barré syndrome (GBS) is six times higher in
people with COVID-19 in the 6 weeks following infection, according to
a new study that also showed receipt of the Pfizer-BioNTech mRNA
vaccine reduced GSB risk by 59% (see "mRNA Vaccine Cuts COVID-Related
Guillain-Barré Risk" under Vaccines, Treatment & Testing).

The May 11, 2023 termination of the PHE has made it increasingly
difficult to accurately track COVID-19 new cases or fatalities.
However, new variants of concern continue to emerge, with consequent
infections and deaths.

Since the termination of the PHE, data on vaccination rates are no
longer being tracked. The last known US COVID-19 vaccination rates
(May 10, 2023) are as follows: full
vaccination (two initial doses) 69.3%; at least one updated booster
dose: 17% (see "Track Covid-19 in the U.S." under
Vaccines, Treatment & Testing). "Our World in Data" stopped trying to
track US booster rates on August 30, 2022 and shows a flat line since
then.


Virology & Epidemiology:

COVID-19 Dashboard by the Center for Systems Science and Engineering
(CSSE) at Johns Hopkins University (JHU):
https://coronavirus.jhu.edu/map.html
and
https://coronavirus.jhu.edu/region/united-states

Our World in Data:
https://ourworldindata.org/coronavirus-data

Worldometer:
https://www.worldometers.info/coronavirus/

Health Equity Tracker:
https://healthequitytracker.org/exploredata?gclid=Cj0KCQjw-4SLBhCVARIsACrhWLUL78j0e9QYUZtcHe_eMhwzCgsIqClo1P9-7GVeRfEW8ewY8Xi7o0QaApCmEALw_wcB

New COVID Variant JN.1 Could Disrupt Holiday Plans:
https://www.medscape.com/s/viewarticle/new-covid-variant-jn-1-could-disrupt-holiday-plans-2023a1000uml

New SARS-CoV-2 variant JN.1 shows increased transmissibility and
immune resistance:
https://www.news-medical.net/news/20231211/New-SARS-CoV-2-variant-JN1-shows-increased-transmissibility-and-immune-resistance.aspx

Update on SARS-CoV-2 Variant JN.1 Being Tracked by CDC:
https://www.cdc.gov/respiratory-viruses/whats-new/SARS-CoV-2-variant-JN.1.html

New CDC Advisory Once Again Flags BA.2.86 COVID Variant:
https://www.medscape.com/s/viewarticle/998895?src=FYE


Vaccines, Treatment & Testing:

Current U.S. COVID Vaccination Rate:
https://www.google.com/search?q=us+covid+vaccination+rate&rlz=1C1CHBF_enUS936US936&oq=us+covid+vaccination+rate+&aqs=chrome..69i57j0i512l7j0i457i512j0i512.4456j0j7&sourceid=chrome&ie=UTF-8

Track Covid-19 in the U.S.:
https://www.nytimes.com/interactive/2023/us/covid-cases.html

Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing
COVID-19–Associated Emergency Department and Urgent Care Encounters
Among Children Aged 6 Months–5 Years:
https://www.medscape.com/viewarticle/995604?src=FYE

Nirmatrelvir-Ritonavir Ineffective at Reducing Most Post-COVID Conditions:
https://www.medscape.com/viewarticle/997878?ecd=wnl_dne1_231101_MSCPEDIT_etid6012787&uac=397605ET&impID=6012787

mRNA Vaccine Cuts COVID-Related Guillain-Barré Risk:
https://www.medscape.com/viewarticle/997761?src=FYE


Policy:

6% of Workers' Comp Cases Are for Long COVID, But Many Can't Collect:
https://www.medscape.com/viewarticle/997416?src=FYE

Federal Program Offers Free COVID, Flu At-Home Tests, Treatments:
https://www.medscape.com/s/viewarticle/federal-program-offers-free-covid-flu-home-tests-treatments-2023a1000urv?src=FYE


COVID Complications:

Wide Regional Variation in Diagnosis of Long COVID:
https://www.medscape.com/viewarticle/wide-regional-variation-diagnosis-long-covid-2023a1000un0?ecd=wnl_dne2_231211_MSCPEDIT_etid6146387&uac=397605ET&impID=6146387

Sensory Comeback: New Findings Show the Path to Smell and Taste
Recovery After COVID:
https://www.medscape.com/viewarticle/998297?src=FYE

COVID Coronary Plaque Infection Confirms CV Risk:
https://www.medscape.com/viewarticle/997638?src=FYE


Media News:

'Tripledemic': Your Questions Answered:
https://www.medscape.com/viewarticle/998421?src=FYE


Hoping that is helpful information, and happy holidays--

Chuck

Charles M. Lepkowsky, Ph.D.
Solvang, CA
[email protected]

#psychology #counseling #socialwork #psychotherapy #research   
@[email protected] @[email protected] @[email protected]   
@[email protected] #Vaccines #COVID #longcovid #science #medicine   
#covid19 #coronavirus #sars-cov-2 #covidisnotover #CDC   
@[email protected] @[email protected] @[email protected]   
#depression #anxiety #sleep #brainfog

.  
.  
Private, vetted email list for mental health professionals: <https://www.clinicians-exchange.org>  
Open Mastodon instance for all mental health workers: <https://mastodon.clinicians-exchange.org>  
.  
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @[email protected]   
.  
 Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: <https://www.nationalpsychologist.com>  
.  
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:  
<http://subscribe-article-digests.clinicians-exchange.org>  
.  
READ ONLINE: <http://read-the-rss-mega-archive.clinicians-exchange.org>  
It's primitive... but it works... mostly...
admin , to psychology
@admin@mastodon.clinicians-exchange.org avatar

Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Open LEMMY instance for all mental health workers: https://lem.clinicians-exchange.org
.

TITLE: COVID News

Thank you Dr. Lepkowsky

-------- Forwarded Message --------

Disclaimer: The data in this column come from either mainstream news
media sources or scientific research published in peer-reviewed
journals (each category can be determined by following the links in
the reference section). This column's author acknowledges the cultural
bias of the world scientific community in its belief that the
scientific method is the most viable available alternative for
assessing COVID-19 and its effects in an objective manner through a
structured process of observable and repeatable hypothesis testing.

Summary: Hospitalizations from COVID-19 rose for an eighth straight
week to 18,871 people/week see "COVID Hospitalizations Rise for Eighth
Week in a Row" under Virology & Epidemiology).

Moderna says its upcoming COVID-19 vaccine should work against the
BA.2.86 variant that has caused worry about a possible surge in cases
(see "New Moderna Vaccine to Work Against Recent COVID Variant" under
Vaccomes, Treatment & Testing).

COVID vaccines will have a new formulation this year, according to a
decision announced today by the US Food and Drug Administration that
will focus efforts on circulating variants. The move pushes last
year's bivalent vaccines out of circulation because they will no
longer be authorized for use in the United States (see "New COVID
Vaccines Force Bivalents Out" under Policy).

The CDC is not specifically saying whether long COVID patients should
get the new COVID boosters, flu shots, or RSV vaccines, and the Food
and Drug Administration (FDA) referred similar questions to the CDC
(see "Should Long COVID Patients Get the Flu, RSV, and New Booster
Shots?" under Policy).

Research continues to show that early intervention with antibiotics
reduces the risk of fatality from COID-19 (see "Early Empiric
Antibiotic Use in Patients Hospitalized With COVID-19" under Vaccines,
Treatment & Testing).

In ICU-patients ≥70 years old, COVID-19 is associated with greater
mortality rates than bacterial or viral pneumonia (see "Increased
Mortality in ICU Patients ≥70 Years Old With COVID-19 Compared to
Patients With Other Pneumonias" under COVID Complications).

After the US Food and Drug Administration authorized new monovalent
COVID vaccines, the CDC recommended the new booster vaccinations for
everyone (see "Universal Monovalent COVID Vaccines Backed by CDC"
under Policy).

About 103 million Americans had COVID-19, and about a third of those
led to long COVID. New data indicate that some cases of long COVID-19
might be going unidentified because the patient's initial infection
wasn't detected (see "Some People With Long COVID Tested Negative for
COVID-19" under COVID Complications).

Although SARS-CoV-2 infection among young children typically results
in mild infection, it can result in serious illness, including
multisystem inflammatory syndrome in children, long-term sequalae, and
death. mRNA COVID-19 vaccination provides protection against
symptomatic SARS-CoV-2 infection for at least 4 months after
vaccination among children aged 3–5 years (see "Safety Monitoring of
mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months–5
Years" under Vaccines, Treatment & Testing).

A new meta-analysis has shown that SGLT2 inhibitors do not lead to
lower 28-day all-cause mortality compared with usual care or placebo
in patients hospitalized with COVID-19 (see "SGLT2-inhibitors: No
Benefit in Hospitalized COVID-19" under Vaccines, Treatment &
Testing).

The COVID-19 booster vaccine typically causes transient, clinically
insignificant elevations in glucose levels in people with type 1
diabetes (see "COVID Booster May Transiently Raise Glucose Levels in
T1D" under Vaccines, Treatment & Testing).

"Cost May Lead Many to Skip COVID Testing: Why That's a Problem" (see
under Media News).

The May 11, 2023 termination of the PHE has made it increasingly
difficult to accurately track COVID-19 new cases or fatalities.
However, new variants of concern continue to emerge, with consequent
infections and deaths.

Since the termination of the PHE, data on vaccination rates are no
longer being tracked. The last known US COVID-19 vaccination rates
(May 10, 2023) are as follows: full
vaccination (two initial doses) 69.3%; at least one updated booster
dose: 17% (see "Track Covid-19 in the U.S." under
Vaccines, Treatment & Testing). "Our World in Data" stopped trying to
track US booster rates on August 30, 2022 and shows a flat line since
then.


Virology & Epidemiology:

COVID-19 Dashboard by the Center for Systems Science and Engineering
(CSSE) at Johns Hopkins University (JHU):
https://coronavirus.jhu.edu/map.html
and
https://coronavirus.jhu.edu/region/united-states

Our World in Data:
https://ourworldindata.org/coronavirus-data

Worldometer:
https://www.worldometers.info/coronavirus/

Health Equity Tracker:
https://healthequitytracker.org/exploredata?gclid=Cj0KCQjw-4SLBhCVARIsACrhWLUL78j0e9QYUZtcHe_eMhwzCgsIqClo1P9-7GVeRfEW8ewY8Xi7o0QaApCmEALw_wcB

COVID Hospitalizations Rise for Eighth Week in a Row:
https://www.medscape.com/s/viewarticle/996410?ecd=wnl_dne1_230915_MSCPEDIT_etid5855961&uac=397605ET&impID=5855961


Vaccines, Treatment & Testing:

Current U.S. COVID Vaccination Rate:
https://www.google.com/search?q=us+covid+vaccination+rate&rlz=1C1CHBF_enUS936US936&oq=us+covid+vaccination+rate+&aqs=chrome..69i57j0i512l7j0i457i512j0i512.4456j0j7&sourceid=chrome&ie=UTF-8

Track Covid-19 in the U.S.:
https://www.nytimes.com/interactive/2023/us/covid-cases.html

Early Empiric Antibiotic Use in Patients Hospitalized With COVID-19:
https://www.medscape.com/s/viewarticle/995862?ecd=wnl_edit_tpal_etid5834655&uac=397605ET&impID=5834655

New Moderna Vaccine to Work Against Recent COVID Variant:
https://www.medscape.com/s/viewarticle/996213?ecd=WNL_trdalrt_pos1_230910_etid5840723&uac=397605ET&impID=5840723

Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children
Aged 6 Months–5 Years:
https://www.medscape.com/viewarticle/993043

SGLT2-inhibitors: No Benefit in Hospitalized COVID-19:
https://www.medscape.com/viewarticle/996426?ecd=wnl_dne10_230915_MSCPEDIT_etid5855961&uac=397605ET&impID=5855961

COVID Booster May Transiently Raise Glucose Levels in T1D:
https://www.medscape.com/viewarticle/996455?ecd=wnl_dne4_230915_MSCPEDIT_etid5855961&uac=397605ET&impID=5855961


Policy:

New COVID Vaccines Force Bivalents Out:
https://www.medscape.com/s/viewarticle/996300?ecd=wnl_newsalrt_230911_MSCPEDIT_New_Covid_etid5843749&uac=397605ET&impID=5843749

Should Long COVID Patients Get the Flu, RSV, and New Booster Shots?:
https://www.medscape.com/viewarticle/996286?ecd=WNL_trdalrt_pos1_230911_etid5844198&uac=397605ET&impID=5844198

Universal Monovalent COVID Vaccines Backed by CDC:
https://www.medscape.com/viewarticle/996378?ecd=wnl_dne4_230914_MSCPEDIT_etid5852504&uac=397605ET&impID=5852504


COVID Complications:

Increased Mortality in ICU Patients ≥70 Years Old With COVID-19
Compared to Patients With Other Pneumonias:
https://www.medscape.com/s/viewarticle/994778?src=FYE

Some People With Long COVID Tested Negative for COVID-19:
https://www.medscape.com/s/viewarticle/995857?src=FYE


Media News:

Cost May Lead Many to Skip COVID Testing: Why That's a Problem:
https://www.medscape.com/s/viewarticle/996471?ecd=wnl_edit_tpal_etid5857656&uac=397605ET&impID=5857656


Hoping that is helpful information--

Chuck

Charles M. Lepkowsky, Ph.D.
Solvang, CA
[email protected]

~~

#psychology #counseling #socialwork #psychotherapy #research   
@[email protected] @[email protected] @[email protected]   
@[email protected] #Vaccines #COVID #longcovid #science #medicine   
#covid19 #coronavirus #sars-cov-2 #covidisnotover #CDC   
@[email protected] @[email protected] @[email protected]   
#depression #anxiety #sleep #brainfog #stillnotover  
.  
.  
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can subscribe at @[email protected]
admin , to psychology
@admin@mastodon.clinicians-exchange.org avatar

Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Open LEMMY instance for all mental health workers: https://lem.clinicians-exchange.org
.

TITLE: COVID News

Thank you Dr. Lepkowsky

-------- Forwarded Message --------

Disclaimer: The data in this column come from either mainstream news
media sources or scientific research published in peer-reviewed
journals (each category can be determined by following the links in
the reference section). This column's author acknowledges the cultural
bias of the world scientific community in its belief that the
scientific method is the most viable available alternative for
assessing COVID-19 and its effects in an objective manner through a
structured process of observable and repeatable hypothesis testing.

Summary: The updated vaccine that better protects against currently
circulating strains of the virus that causes COVID-19 may be available
as soon as next week (see "New COVID Shots Could Be Available Next
Week" under Vaccines, Treatment & Testing).

The increase in cases of COVID-19 in the northern hemisphere is
worrying healthcare authorities around the world, who are aware that
these countries usually experience a peak in respiratory infections
during the winter months (see "WHO 'Concerned' About COVID Increase in
Northern Hemisphere" under Virology & Epidemiology).

COVID-19 hospitalizations have been on the rise for weeks as summer
nears its end. COVID-19 hospitalizations rose by 19% last week and
COVID deaths by 21%, according to figures from the CDC. More than half
the states, 26, had a "substantial increase" in hospital admissions
(see "COVID-19 Hospitalizations and Deaths on the Rise" and "5
Questions for COVID Experts: How Concerned Should We Be?" under
Virology & Epidemiology).

COVID metrics have risen steadily since June after reaching the lowest
point since the pandemic started. However, just 7% of U.S. adults are
"very worried" about getting COVID-19 (see "COVID Metrics Tick Up, but
Americans Aren't Worried: Poll" under Media News).

The CDC and the World Health Organization have dubbed the BA 2.86
variant of COVID-19 as a variant to watch (see "Q&A: What to Know
About the New BA 2.86 COVID Variant" under Virology & Epidemiology).
However, BA.2.86 does not have a heightened ability to evade the
protection of COVID vaccines or immunity from prior infection (see
"Highly Mutated COVID Strain Can't Evade Immunity as Feared" under
Virology & Epidemiology).

Close and prolonged contact with someone with COVID-19 can more than
quadruple the risk of getting the virus (see "This Is When You're Most
at Risk for 'Leaky' COVID Immunity" under Virology & Epidemiology).

It's estimated that 1 out of 8 people with COVID develop long COVID.
Of those persons, 44% also experience headaches. Research has found
that many of those headaches are migraines — and many patients who are
afflicted say they had never had a migraine before (see "Long COVID
and New Migraines: What's the Link?" under COVID Complications).

Severe COVID infections may lead to lasting damage to the immune
system (see "Severe COVID May Cause Long-Term Cellular Changes: Study"
under COVID Complications).

COVID-19 may negatively affect the wound healing process while
increasing the mortality rate amongst patients with multiple or severe
comorbidities undergoing limb salvage procedure (see "Retrospective
Review of Complications and Outcomes in COVID-19–Positive Patients
With Comorbidities Undergoing Limb Salvage Procedures in a Tertiary
Care Wound Center" under COVID Complications).

Among patients with ARF due to COVID-19 pneumonia who fail HFNC, delay
of intubation beyond 24 h is associated with increased mortality (see
"Delayed Intubation Associated With In-hospital Mortality in Patients
With COVID-19" under Vaccines, treatment & Testing).

Crippling symptoms, lost careers, and eroded incomes: This is the
harsh reality for doctors suffering with long COVID, according to the
first major survey of physicians with the condition (see "One in Five
Doctors With Long COVID Can No Longer Work: Survey" under COVID
Complications).

EU regulators have recommended authorizing an updated COVID-19 vaccine
from Pfizer and its German partner BioNTech which targets the dominant
XBB.1.5 variant of Omicron, putting it on track to become the third
adapted shot by the two companies to be approved in the bloc (see "EU
Regulators Back Pfizer's Updated Vaccine for Dominant Omicron
Subvariant" under Policy).

The May 11, 2023 termination of the PHE has made it increasingly
difficult to accurately track COVID-19 new cases or fatalities.
However, new variants of concern continue to emerge, with consequent
infections and deaths.

Since the termination of the PHE, data on vaccination rates are no
longer being tracked. The last known US COVID-19 vaccination rates
(May 10, 2023) are as follows: full
vaccination (two initial doses) 69.3%; at least one updated booster
dose: 17% (see "Track Covid-19 in the U.S." under
Vaccines, Treatment & Testing). "Our World in Data" stopped trying to
track US booster rates on August 30, 2022 and shows a flat line since
then.


Virology & Epidemiology:

COVID-19 Dashboard by the Center for Systems Science and Engineering
(CSSE) at Johns Hopkins University (JHU):
https://coronavirus.jhu.edu/map.html
and
https://coronavirus.jhu.edu/region/united-states

Our World in Data:
https://ourworldindata.org/coronavirus-data

Worldometer:
https://www.worldometers.info/coronavirus/

Health Equity Tracker:
https://healthequitytracker.org/exploredata?gclid=Cj0KCQjw-4SLBhCVARIsACrhWLUL78j0e9QYUZtcHe_eMhwzCgsIqClo1P9-7GVeRfEW8ewY8Xi7o0QaApCmEALw_wcB

5 Questions for COVID Experts: How Concerned Should We Be?:
https://www.medscape.com/s/viewarticle/995997?ecd=wnl_edit_tpal_etid5807826&uac=397605ET&impID=5807826

This Is When You're Most at Risk for 'Leaky' COVID Immunity:
https://www.medscape.com/s/viewarticle/996037?ecd=wnl_dne2_230901_MSCPEDIT_etid5810003&uac=397605ET&impID=5810003

COVID-19 Hospitalizations and Deaths on the Rise:
https://www.medscape.com/s/viewarticle/996070?ecd=wnl_dne1_230904_MSCPEDIT_etid5818745&uac=397605ET&impID=5818745

WHO 'Concerned' About COVID Increase in Northern Hemisphere:
https://www.medscape.com/viewarticle/996186?ecd=WNL_trdalrt_pos1_230907_etid5831889&uac=397605ET&impID=5831889

Highly Mutated COVID Strain Can't Evade Immunity as Feared:
https://www.medscape.com/s/viewarticle/996168


Vaccines, Treatment & Testing:

Current U.S. COVID Vaccination Rate:
https://www.google.com/search?q=us+covid+vaccination+rate&rlz=1C1CHBF_enUS936US936&oq=us+covid+vaccination+rate+&aqs=chrome..69i57j0i512l7j0i457i512j0i512.4456j0j7&sourceid=chrome&ie=UTF-8

Track Covid-19 in the U.S.:
https://www.nytimes.com/interactive/2023/us/covid-cases.html

New COVID Shots Could Be Available Next Week:
https://www.medscape.com/s/viewarticle/996172?ecd=wnl_dne1_230908_MSCPEDIT_etid5832957&uac=397605ET&impID=5832957

Delayed Intubation Associated With In-hospital Mortality in Patients
With COVID-19:
https://www.medscape.com/s/viewarticle/995003?ecd=wnl_dne3_230908_MSCPEDIT_etid5832957&uac=397605ET&impID=5832957


Policy:

EU Regulators Back Pfizer's Updated Vaccine for Dominant Omicron Subvariant:
https://www.medscape.com/s/viewarticle/995971?ecd=wnl_dne7_230901_MSCPEDIT_etid5810003&uac=397605ET&impID=5810003


COVID Complications:

Severe COVID May Cause Long-Term Cellular Changes: Study:
https://www.medscape.com/s/viewarticle/995905?ecd=wnl_sci_tech_230830_MSCPEDIT_etid5799377&uac=397605ET&impID=5799377

Retrospective Review of Complications and Outcomes in
COVID-19–Positive Patients With Comorbidities Undergoing Limb Salvage
Procedures in a Tertiary Care Wound Center:
https://www.medscape.com/s/viewarticle/995502?ecd=wnl_edit_tpal_etid5807826&uac=397605ET&impID=5807826

One in Five Doctors With Long COVID Can No Longer Work: Survey:
https://www.medscape.com/viewarticle/996030?ecd=wnl_dne4_230901_MSCPEDIT_etid5810003&uac=397605ET&impID=5810003

Long COVID and New Migraines: What's the Link?:
https://www.medscape.com/viewarticle/996197?ecd=wnl_dne4_230908_MSCPEDIT_etid5832957&uac=397605ET&impID=5832957


Media News:

COVID Metrics Tick Up, but Americans Aren't Worried: Poll:
https://www.medscape.com/s/viewarticle/995992?ecd=wnl_edit_tpal_etid5807826&uac=397605ET&impID=5807826


Hoping that is helpful information--

Chuck

Charles M. Lepkowsky, Ph.D.
Solvang, CA
clepkowsky(at)gmail.com

#psychology #counseling #socialwork #psychotherapy #research   
@[email protected] @[email protected] @[email protected]   
@[email protected] #Vaccines #COVID #longcovid #science #medicine   
#covid19 #coronavirus #sars-cov-2 #covidisnotover #CDC   
@[email protected] @[email protected] @[email protected]   
#depression #anxiety #sleep #brainfog

.  
.  
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can subscribe at @[email protected]
admin , to psychology
@admin@mastodon.clinicians-exchange.org avatar

Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Open LEMMY instance for all mental health workers: https://lem.clinicians-exchange.org
.

*TITLE: Photobiomodulation for Long COVID (Get Some Sun)
*https://m.youtube.com/watch?v=lLDYNoIVLmk
<https://m.youtube.com/watch?v=lLDYNoIVLmk&pp=ygUhcGhvdG9iaW9tb2R1bGF0aW9uIGZvciBsb25nIGNvdmlk>

Okay all -- It's early days for figuring out how to help people with
Long COVID.

That said, a bit of promising research is starting to surface.

I'm taking the unusual step of emailing EVERYONE because at this point
many of you with anxiety and depression symptoms may have some Long
COVID (brain fog, sleep issues, the depression or anxiety itself!).

A good write-up about what Long COVID is can be found here. Yes, you
can had a trivial case of COVID-19 and still get Long COVID symptoms for
days, weeks, months, or years. Some cases of it are somewhat "mild":
https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html

*The bottom-line of the video is right at the end. For long COVID:
-- Get outside one hour per day.
-- May cover up if sensitive to sun (near UV rays will get through
clothing anyway)
-- Best if in nature (surrounded by green)
-- Do not look directly at sun (duh)
-- May wear a hat (near UV rays will get through clothing anyway)
-- Sitting in a sunny window no longer good enough (most glass now has
to be certified to block the rays we want)

He also promises to talk about how intermittent fasting may help in a
future video.
*
Roger Seheult, MD is the co-founder and lead professor at
https://www.medcram.com/
He is Board Certified in Internal Medicine, Pulmonary Disease, Critical
Care, and Sleep Medicine and an Associate Professor at the University of
California, Riverside School of Medicine. He is also an ER doctor.

Before the pandemic, MedCram mainly seemed to be training for doctors to
pass exams. Since the start of COVID, Dr. Seheult has done occasional
more accessible videos for the general public on COVID-related topics.

To actually understand why something this simple may help -- and listen
to some research, please watch:

Photobiomodulation for Long COVID (Get Some Sun)*
*https://m.youtube.com/watch?v=lLDYNoIVLmk
<https://m.youtube.com/watch?v=lLDYNoIVLmk&pp=ygUhcGhvdG9iaW9tb2R1bGF0aW9uIGZvciBsb25nIGNvdmlk>

Show Notes and Research Links:*
*
(This video was recorded on August 27th, 2023)

LINKS / REFERENCES:

The NIH has poured $1 billion into long Covid research — with little to
show for it (STAT) |
https://www.statnews.com/2023/04/20/long-covid-nih-billion/

Debunking the False Claim That COVID Death Counts Are Inflated
(Scientific American) |
https://www.scientificamerican.com/article/debunking-the-false-claim-that-covid-death-counts-are-inflated1/

Associations of Outdoor Temperature, Bright Sunlight, and
Cardiometabolic Traits in Two European Population-Based Cohorts (JCEM) |
https://academic.oup.com/jcem/article/104/7/2903/5315432?login=false

Photobiomodulation Improves Serum Cytokine Response in Mild to Moderate
COVID-19: The First Randomized, Double-Blind, Placebo Controlled, Pilot
Study (Frontiers) |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304695/pdf/fimmu-13-929837.pdf

A case of COVID-encephalopathy imaged with fMRI and treated with near
infrared light (Brain Stimulation) |
https://www.brainstimjrnl.com/article/S1935-861X(21)00235-7/fulltext

Use of either transcranial or whole-body photobiomodulation treatments
improves COVID-19 brain fog (Journal of Biophotonics) |
https://onlinelibrary.wiley.com/doi/full/10.1002/jbio.202200391

Light spectrum in nanometer (ResearchGate) |
https://www.researchgate.net/figure/Fig-3-Penetration-depth-of-light-into-tissue-according-to-its-wavelength_fig3_282040732

Melatonin and the Optics of the Human Body (Melatonin Research) |
https://www.melatonin-research.net/index.php/MR/article/view/19

Ultraviolet A radiation and COVID-19 deaths in the USAwith replication
studies in England and Italy (BJD) |
https://onlinelibrary.wiley.com/doi/epdf/10.1111/bjd.20093

Sunlight: Optimize Health and Immunity (MedCram) |
https://www.youtube.com/watch?v=5YV_iKnzDRg&t=0s

The Case for Sunlight in COVID 19 Patients: Oxidative Stress (MedCram) |
https://www.youtube.com/watch?v=2Zzo4SJopcY&t=0s

#psychology #counseling #socialwork #psychotherapy #research   
@[email protected] @[email protected] @[email protected]   
@[email protected] #Vaccines #COVID #longcovid #science #medicine   
#covid19 #coronavirus #sars-cov-2 #covidisnotover #CDC   
@[email protected] @[email protected] @[email protected]   
#depression #anxiety #sleep #brainfog  
.  
.  
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can subscribe at @[email protected]
  • All
  • Subscribed
  • Moderated
  • Favorites
  • random
  • lifeLocal
  • goranko
  • All magazines